/-
  MedThermo.Theorems.HLAParadox

  Formalization of the HLA Paradox: no HLA genotype protects against all
  CVB-caused diseases simultaneously.

  The biological content: HLA molecules have finite binding grooves that
  can't efficiently present all possible peptide fragments. Efficient
  presentation of one organ's autoantigens (→ autoimmune risk) trades off
  against efficient presentation of viral peptides (→ rapid clearance)
  and other organ's autoantigens.

  The mathematical content: given a finite set of diseases and a relative risk
  function over HLA genotypes, if every genotype efficiently presents at least
  one autoantigen (biological axiom), then no genotype achieves RR ≤ 1 for
  all diseases simultaneously.

  This is a simple impossibility result — the interesting part is the
  biological axiom, not the logic.
-/

import Mathlib.Data.Fin.Basic
import Mathlib.Data.Fintype.Basic
import Mathlib.Data.Real.Basic
import Mathlib.Tactic

namespace MedThermo.Theorems.HLAParadox

/-! ## The Setup

We model:
- A type `G` of HLA genotypes (finite)
- A type `D` of CVB-caused diseases (12 diseases, indexed by Fin 12)
- A relative risk function `RR : G → Fin 12 → ℝ` mapping each genotype-disease
  pair to a relative risk value

The biological axiom states: for every genotype, there exists at least one
disease where the relative risk exceeds 1 (the genotype presents that organ's
autoantigens efficiently).
-/

/-- **The HLA Paradox Theorem.**

    Given the biological axiom that every HLA genotype efficiently presents
    at least one organ's autoantigens (raising disease risk for that organ),
    no genotype can be universally protective (RR ≤ 1) across all 12 diseases.

    The proof is trivial from the axiom — the content is in the axiom itself,
    which is justified by the finite binding groove of HLA molecules. -/
theorem hla_paradox {G : Type} (RR : G → Fin 12 → ℝ)
    (h_binding : ∀ g : G, ∃ d : Fin 12, 1 < RR g d) :
    ¬ ∃ g : G, ∀ d : Fin 12, RR g d ≤ 1 := by
  push_neg
  intro g
  obtain ⟨d, hd⟩ := h_binding g
  exact ⟨d, hd⟩

/-- **The Negative Correlation Corollary.**

    If organ A's risk and organ B's risk are determined by antigen presentation
    efficiency, and the total presentation capacity is bounded (finite HLA groove),
    then increasing efficiency for organ A's antigens decreases efficiency for
    organ B's antigens. This produces the observed negative correlation between
    T1DM risk and cardiac risk across HLA genotypes.

    Formally: if the sum of presentation efficiencies is bounded, then
    the efficiency values are negatively correlated in a constrained sense. -/
theorem presentation_tradeoff {G : Type}
    (eff_pancreas eff_heart : G → ℝ)
    (total_capacity ε : ℝ)
    (h_bounded : ∀ g : G, eff_pancreas g + eff_heart g ≤ total_capacity)
    (h_nonneg_p : ∀ g, 0 ≤ eff_pancreas g)
    (h_nonneg_h : ∀ g, 0 ≤ eff_heart g) :
    -- If pancreas efficiency is at capacity, heart efficiency must be near 0
    ∀ g : G, eff_pancreas g ≥ total_capacity - ε →
      ε ≥ 0 →
      eff_heart g ≤ ε := by
  intro g hp hε
  linarith [h_bounded g]

/-! ## The Screening Implication

The HLA paradox has a direct clinical consequence: screening should be
HLA-genotype-directed.

- DR3/DR4 carriers: screen for T1DM (islet autoantibodies)
- DQ5 carriers: screen for cardiac disease (troponin, MRI)
- DQ6 carriers: reassure about T1DM, but monitor CNS

The protocol is genotype-agnostic (clears virus from all organs),
but the SCREENING is genotype-specific (check the organ at highest risk first).
-/

end MedThermo.Theorems.HLAParadox
